Online Journals
(Blue) Free Articles
(Green) Subscription Articles
  Volume 13
  Volume 12
  Volume 11
  Volume 10
  Volume 09
  Volume 08
  Volume 07
  Volume 06
  Volume 05
  Volume 04
  Volume 03
  Volume 02
  Volume 01

Note: You can mouseover the page link to see the article's title.

EDITORIAL BOARD

EDITOR-IN-CHIEF

Richard M. Kostrzewa, Department of Pharmacology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA

 

ASSOCIATE EDITORS

Mario Herrera-Marschitz, Program of Molecular & Clinical Pharmacology, University of Chile, Santiago, Chile
Xin-Fu Zhou, Department of Human Physiology, Flinders Univ., So. Australia, Adelaide Australia

 

EDITORIALBOARD

Lucyna Antkiewicz-Michaluk, Institute of Pharmacology, Polish Academy of Science, Krakow, Poland
Gjumrakch Aliev, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA
Trevor Archer, Department of Psychology, Universities of Göteborg and Kalmar, Sweden
Richard J. Beninger, Department of Psychology, Queen’s University, Kingston ON, Canada
C. LeRoy Blank, Department of Chemistry & Biochemistry, University of Oklahoma, Norman, OK, USA
Ryszard Brus, Department of Pharmacology, Medical University of Silesia, Zabrze, Poland
D. Allan Butterfield, Department of Chemistry, University of Kentucky, Lexington, KY, USA
Jean Lud Cadet, Molecular Neuropsychiatry Section, NIDA, Baltimore, MD, USA
Neal Castagnoli Jr., Department of Chemistry, Virginia Polytechnic Institute and State Univ., Blacksburg, VA, USA
Rudy J. Castellani, Department of Neuropathology, University of Maryland, Baltimore, MD, USA
Sandra Ceccatelli, Division of Toxicology & Neurotoxicology, Karolinska Institute, Stockholm, Sweden
Stanislaw Czuczwar, Department of Pharmacology & Toxicology, Lublin Medical University, Poland
Wojciech Danysz, Department of Behavioral Pharmacology, Merz+Co., Frankfurt am Main, Germany
Glenn Dryhurst, Department of Chemistry & Biochemistry, University of Oklahoma, Norman, OK, USA
Keith Foster, Syntaxin Ltd., Porton Down, Salisbury, UK
Howard E. Gendelman, Ctr. Neurovirology & Neurodegenerative Disorders, Univ. Nebraska Med. Ctr, Omaha, NE.
Mark Geyer, Department of Psychiatry & Neurosciences, University of California, San Diego, CA, USA
Gilles Guillemin, Center for Immunology, School of Medical Sciences, St. Vincent’s Hospital, Sydney, Australia
Ellen J. Hess, Departments of Neurology & Neuroscience, Johns Hopkins University, Baltimore, MD, USA
Hrissanthi Ikonomidou, Department of Pediatric Neurology, Technical University, Dresden, Germany
David M. Jacobowitz, Department of Anatomy, Uniformed Services University, Bethesda, MD, USA
Joseph Jankovic, Dept. Neurology & Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA
Kristen A. Keefe, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, USA
J. William Langston, The Parkinson’s Institute, Sunnyvale, CA, USA
Johan Luthman, Section on Neurosciences, Serono Pharmaceutical Co., Geneva, Switzerland
Mark Mattson, Chief, Laboratory of Neurosciences, NIA/NIH, Baltimore, MD, USA
Italo Mocchetti, Department of Neuroscience, Georgetown University, Washington DC, USA
Micaela Morelli, Department of Toxicology, University of Cagliari, Italy
Tomas Palomo, Fundación Cerebro y Mente, Madrid, Spain
Vijayalakshmi Ravindranath, National Brain Research Centre, Gurgaon, Haryana, India
Peter Riederer, Clinic/Polyclinic, Psychiatry & Psychotherapy, University of Wuerzburg, Germany
Paul R Sanberg, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL, USA
Giampetro Schiavo, Molecular NeuroPathoBiology Lab, Cancer Research UK, London, UK
Rainer K.W. Schwarting, Experimental Physiology & Psychology, Philipps-University of Marburg, Germany
Juan Segura-Aguilar, Programa de Farmacologia Molecular y Clinica, Universidad de Chile, Casilla- Santiago, Chile
David H. Small, Lab. Molec. Neurobiology, Dept. Biochemistry & Molec. Biology, Monash Univ., Victoria, Australia
Mark A. Smith, Institute of Pathology, Case Western Reserve University, Cleveland, OH, USA
Pierre Sokoloff, Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM, Paris, France
Peter S. Spencer, Ctr. Res. Occupational & Environmental Toxicology, Oregon Health & Science Univ., Portland, OR.
David Sulzer, Departments of Psychiatry and Neurology, Columbia University, New York, NY, USA
Matthew J. Wayner, Division of Life Sciences, University of Texas at San Antonio, TX, USA
Moussa B. Youdim, Department of Pharmacology, Technion-Faculty of Medicine, Rappaport Center, Haifa, Israel